
Dietitian: The brutally honest fat loss advice I'd give you if I WASN'T worried about hurting your feelings
An Australian dietitian has delivered a no-nonsense message about why so many people struggle to lose weight.
Leanne Ward, a Brisbane-based dietitian and nutritionist, is known for her straight-talking posts on Instagram.
But it was a recent one titled 'Warning: this may hurt... but you need to hear it' that cut straight to the heart of the issue.
In it, Ward listed the hard truths she often sees behind her clients' struggles, challenging some of the most common explanations people give for not losing fat.
'It's not your metabolism - you're just not consistent,' she wrote.
'A calorie deficit does work - you're just not in one. It's not your hormones - it's the snacking, poor sleep and no structure.'
She continued with more wake-up calls: 'You don't need a gut cleanse - you need more fibre, plants and less ultra-processed food,' and 'You're not addicted to sugar - you're under-fuelled, over-stressed and emotionally exhausted.'
While the message may sound blunt, Ward isn't dismissing the genuine struggles many people face.
In fact, she acknowledged that medical conditions and complex factors do play a role in some cases - but argued that, in her experience, they account for 'the few, not the many'.
Her words have sparked a huge response online, with thousands sharing and commenting in agreement.
So what does this actually mean for everyday Australians trying to improve their health?
The overarching message is simple: consistency matters more than perfection.
Many people assume their efforts 'aren't working' after a week or two of healthy eating or exercise, but real change requires months of sustained habits.
Tracking food honestly, setting regular meal times, and reducing mindless snacking are all small, tangible ways to get back on track.
Ward's reminder about sleep and stress is also crucial.
Lack of sleep and high stress levels can throw off hunger signals, fuel emotional eating, and make people crave sugary, high-calorie foods.
Creating simple routines around bedtime, incorporating movement into the day, and asking for help when overwhelmed can all make a difference, not just for fat loss, but for overall wellbeing.
She also touched on a growing trend: intuitive eating.
While it works well for some, Ward warned that if someone is used to overeating, their internal hunger and fullness cues may be unreliable.
In those cases, eating 'intuitively' might not be effective until habits and signals are reset.
Finally, Ward's post ended with a reality check: 'You say you've tried everything - but you haven't been consistent with anything.'
It's a statement that resonated with thousands, and one that many say helped them reflect on their own patterns.
In a time when social media is flooded with quick fixes, detoxes, and conflicting advice, Ward's post serves as a much-needed reminder that health doesn't need to be complicated - but it does require honesty, structure, and patience.
Her advice may not be sugar-coated, but for many, it might be exactly what they need to hear.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Guardian
24 minutes ago
- The Guardian
Private matters: getting frank about healthcare terms
Has a hefty load of healthcare lingo given you a sore head? Between levies, loadings and penalties, it's easy to feel jaded by the jargon. However, if you're entering your late 20s, the (somewhat uncomfortable) truth is that you're approaching the no-turning-back years that could affect the healthcare costs you'll pay for decades. It's worth thinking about your options, especially before tax time. Lifetime health cover (LHC) loading encourages younger Australian adults to take out private hospital cover before 1 July in the year after they turn 31. After this point, they risk facing higher premiums for a decade under the government's LHC loading policy. How much are we talking? If you don't have private hospital cover by 1 July following your 31st birthday you will be charged an extra 2% on top of your premium for every year you are over 30, and this will remain in place for 10 years. So, if you wait until you're 36 years old to take out eligible hospital cover for the first time, you'll pay an extra 12% for hospital cover per year, for 10 years. At 45, that figure will be 30%. Frank Health Insurance offers a simple guide to LHC, which is a good place to start if you're unsure how your age might affect future premium costs. Health cover decisions can have tax implications. The Medicare levy surcharge (MLS) and the Medicare levy have recently been in the news. The Medicare levy is relatively straightforward: it's a 2% tax levied on your taxable income. Most Australians pay it, though lower income earners can qualify for a levy reduction, or may not have to pay it at all. A single person earning less than $27,222, or a family earning less than $45,907 (this increases by $4,216 for each dependent child), don't have to pay the Medicare levy. The Medicare levy surcharge increases the levy for higher earners. Singles earning more than $97,000 are subject to an additional 1% levy. This rises to 1.25% for incomes above $113,000, and 1.5% above $151,000. For families, the thresholds are $194,000, $226,000 and $302,000 (plus $1,500 for each dependent child after the first child). Note that the Medicare levy surcharge rates and income thresholds will change in July 2025. With the end of the financial year approaching, now is an ideal time to discuss the tax implications of taking out private health cover with an expert. Frank Health Insurance's MLS guide, written by policy experts with industry knowledge, explains how taking out an appropriate level of private health cover may mean you don't have to pay the MLS – and can reduce your tax bill. Always discuss your personal financial situation with a qualified financial adviser. The Pharmaceutical Benefits Scheme (PBS) is Australia's pricing system for prescription medications, covering everything from antibiotics and Ventolin to insulin and mental health medication. It's a public safety net designed to keep essential medicines affordable and accessible. Under the PBS, the government covers most of the cost of essential medicines, so you pay a set co-payment only, which is commonly less than the full retail price. It works alongside Medicare and private health cover, with the goal of ensuring that no Australian is priced out of treatment. Without the PBS, a trip to the chemist would be much more expensive. Choose your ideal level of hospital cover.


The Independent
an hour ago
- The Independent
New once-a-month drug could treat diabetes and obesity, scientists say
A new experimental drug meant to be taken just once a month could lead to 'substantial weight reduction' within a year and help overcome both diabetes and obesity, a new clinical trial suggests. Results of the trial, published on Tuesday in the journal NEJM, show that Maridebart cafraglutide, or MariTide, could reduce body weight by up to 20 per cent within a year. Even after 12 months of taking the drug, weight loss had not plateaued in the participants, indicating there was potential for further weight reduction. The drug, developed by pharma company Amgen, targets the same combination of molecules as popular weight loss jabs like Ozempic as well as another pathway involved in insulin release. Weight loss induced by the new drug was found to be accompanied by improvements in heart health measures such as waist circumference, blood pressure and blood levels of circulating fat molecules. 'The data demonstrates the potential for once monthly or less frequent dosing and are particularly encouraging as we seek sustainable, long-term treatments for people living with obesity, with and without type 2 diabetes,' Ania Jastreboff, a study co-author from the Yale School of Medicine, said. The phase 2 trial included nearly 600 people categorised into two cohorts – one with obesity and the other with obesity as well as type 2 diabetes. The obesity group received MariTide subcutaneously at varying doses of 140, 280 or 420mm every four weeks, with the doses carefully increased every few weeks or months for some. The treatment led to an average 20 per cent weight loss in people living with obesity alone and a nearly 17 per cent mean weight loss in those living with obesity and type 2 diabetes, the study found. 'MariTide's monthly or less frequent dosing has the potential to improve adherence and long-term weight control, providing the opportunity to optimise health outcomes for people living with obesity, type 2 diabetes, and related conditions,' said Jay Bradner, executive vice president of research and development at Amgen. The trial found some 'mild to moderate' gut-related side effects in people taking the drug. But these gastrointestinal events were mainly limited to initial dosing and were less frequent when the doses were carefully increased without compromising efficacy, they said. There were no discontinuations due to these side effects at any time during the study, however. Researchers are currently evaluating the drug's effectiveness in reducing weight further among those who already lost 15 per cent of their weight in the latest trial. They also hope to test the drug's effectiveness for weight loss among those with heart disease and obstructive sleep apnea.


The Independent
3 hours ago
- The Independent
Trial finds weight loss drug taken monthly helps people lose 20% of body weight
A new trial has found that a weight loss drug taken monthly helps people lose 20 percent of their body weight. Weight loss medications such as Ozempic, Wegovy and Mounjaro have become popular and now there's a new GLP-1 drug, MariTide, being tested that could be competitive in the market. MariTide, from the drug maker Amgen, is different from the other weight loss drugs as it also has a monoclonal antibody, which allows the medication to stay in the body longer, NBC News health and medical reporter Berkeley Lovelace Jr. explained in an article published Monday. The article dives into a new trial published in The New England Journal of Medicine. Researchers analyzed nearly 600 participants, who were broken up into those with both Type 2 diabetes and obesity and those with obesity. The trial found that those with obesity alone who were treated with MariTide lost up to about 20 percent of their body weight, on average, after 52 weeks. Those with obesity alone who didn't take the MariTide only lost up to 2.6 percent of their body weight, on average. Participants who had diabetes and obesity lost up to 17 percent of their body weight, on average, while taking MariTide, according to researchers. Those with both diseases who weren't on MariTide lost up to 1.4 percent of their body weight, on average. Ozempic and similar drugs can help patients lose 15 to 20 percent of their body weight, according to Columbia University's Department of Surgery. Ozempic and other GLP-1 medications are taken weekly, but MariTide only needs to be taken monthly, making it more convenient for patients. 'It's always just easier for patients to only have to take something once per month,' Dr. Michelle Ponder, an assistant professor of medicine at Duke University School of Medicine in North Carolina, told Lovelace. Ponder, who wasn't a part of the MariTide trial, added: 'A lot of patients we see in endocrinology are diabetes patients, and so they'd be taking multiple shots of insulin per day. And so, every last shot matters, even if it's three less shots per month.' MariTide researchers said gastrointestinal issues were 'common' with the drug, but Lovelace pointed out that the drug's side effects were similar to those of other GLP-1 medications.